alytas

alytas is a spin-off from the University of Jena, aiming to develop new immunotherapy concepts for treating the globally increasing pathological obesity, an unmet medical need so far and one of the three major global social burdens caused by humans. The company possesses relevant expertise and patents for various epitopes and has demonstrated their association with novel therapeutic immune modulation related to excessive fat cells in obese patients.